The multi-sectorial emergency response to a cholera outbreak in Internally Displaced Persons camps in Borno State, Nigeria, 2017.

Borno State Nigeria cholera emergency response internally displaced persons camp monitoring and evaluation qualitative research reactive oral cholera vaccine

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2020
Historique:
received: 16 09 2019
revised: 10 01 2020
accepted: 13 01 2020
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 7 3 2020
Statut: epublish

Résumé

In August 2017, a cholera outbreak started in Muna Garage Internally Displaced Persons camp, Borno state, Nigeria and >5000 cases occurred in six local government areas. This qualitative study evaluated perspectives about the emergency response to this outbreak. We conducted 39 key informant interviews and focus group discussions, and reviewed 21 documents with participants involved with surveillance, water, sanitation, hygiene, case management, oral cholera vaccine (OCV), communications, logistics and coordination. Qualitative data analysis used thematic techniques comprising key words in context, word repetition and key sector terms. Authorities were alerted quickly, but outbreak declaration took 12 days due to a 10-day delay waiting for culture confirmation. Outbreak investigation revealed several potential transmission channels, but a leaking latrine around the index cases' house was not repaired for more than 7 days. Chlorine was initially not accepted by the community due to rumours that it would sterilise women. Key messages were in Hausa, although Kanuri was the primary local language; later this was corrected. Planning would have benefited using exercise drills to identify weaknesses, and inventory sharing to avoid stock outs. The response by the Rural Water Supply and Sanitation Agency was perceived to be slow and an increased risk from a religious festival was not recognised. Case management was provided at treatment centres, but some partners were concerned that their work was not recognised asking, 'Who gets the glory and the data?' Nearly one million people received OCV and its distribution benefited from a robust infrastructure for polio vaccination. There was initial anxiety, rumour and reluctance about OCV, attributed by many to lack of formative research prior to vaccine implementation. Coordination was slow initially, but improved with activation of an emergency operations centre (EOC) that enabled implementation of incident management system to coordinate multisectoral activities and meetings held at 16:00 hours daily. The synergy between partners and government improved when each recognised the government's leadership role. Despite a timely alert of the outbreak, delayed laboratory confirmation slowed initial response. Initial responses to the outbreak were not well coordinated but improved with the EOC. Understanding behaviours and community norms through rapid formative research should improve the effectiveness of the emergency response to a cholera outbreak. OCV distribution was efficient and benefited from the polio vaccine infrastructure.

Identifiants

pubmed: 32133173
doi: 10.1136/bmjgh-2019-002000
pii: bmjgh-2019-002000
pmc: PMC7042583
doi:

Substances chimiques

Cholera Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e002000

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Emerg Infect Dis. 2017 Jan;23(1):38-45
pubmed: 27983502
Sci Total Environ. 2018 Oct 1;637-638:1455-1465
pubmed: 29801238
Am J Trop Med Hyg. 2009 Apr;80(4):640-5
pubmed: 19346392
BMC Public Health. 2014 Nov 16;14:1167
pubmed: 25399402
Glob Health Sci Pract. 2016 Dec 28;4(4):626-646
pubmed: 28031301
J Health Commun. 2017;22(sup1):24-30
pubmed: 28854130
Sci Rep. 2016 Oct 24;6:35742
pubmed: 27775046
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Am J Trop Med Hyg. 2018 May;98(5):1269-1274
pubmed: 29512484
Niger Med J. 2015 May-Jun;56(3):161-8
pubmed: 26229222
PLoS Med. 2015 Nov 17;12(11):e1001901
pubmed: 26576044
Emerg Infect Dis. 2011 Nov;17(11):2136-8
pubmed: 22099118
J Health Commun. 2017;22(sup1):39-50
pubmed: 28854137
Int J Health Geogr. 2008 Dec 16;7:62
pubmed: 19087235
Pan Afr Med J. 2016 Apr 20;23:203
pubmed: 27347292
Lancet Glob Health. 2016 Nov;4(11):e856-e863
pubmed: 27765293
J Infect Dev Ctries. 2012 Mar 12;6(3):234-41
pubmed: 22421604
BMJ Glob Health. 2019 Jul 15;4(4):e001709
pubmed: 31406596
Emerg Infect Dis. 2016 Jun;22(6):1067-70
pubmed: 27192187
Wkly Epidemiol Rec. ;92(34):477-98
pubmed: 28845659
Pan Afr Med J. 2017 Dec 15;28:311
pubmed: 29721141
Health Manpow Manage. 1997;23(2-3):97-9
pubmed: 10167883
J Water Health. 2008 Dec;6(4):559-64
pubmed: 18401121
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000
Epidemiol Infect. 2012 Aug;140(8):1376-85
pubmed: 21943798

Auteurs

Moise Chi Ngwa (MC)

International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Alemu Wondimagegnehu (A)

World Health Organisation, Nigeria Country Office, Abuja, Nigeria.

Ifeanyi Okudo (I)

World Health Organisation, Nigeria Country Office, Abuja, Nigeria.

Collins Owili (C)

World Health Organisation, Nigeria Country Office, Abuja, Nigeria.

Uzoma Ugochukwu (U)

World Health Organisation, Nigeria Country Office, Abuja, Nigeria.

Peter Clement (P)

World Health Organisation, Nigeria Country Office, Abuja, Nigeria.

Isabelle Devaux (I)

World Health Organization, Maiduguri, Nigeria.

Lorenzo Pezzoli (L)

World Health Organization, Geneve, Switzerland.

Chikwe Ihekweazu (C)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Mohammed Abba Jimme (MA)

Geography, University of Maiduguri Faculty of Social Science, Maiduguri, Nigeria.

Peter Winch (P)

International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

David A Sack (DA)

International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH